Your browser doesn't support javascript.
loading
Higher prevalence of splenic artery aneurysms in hereditary hemorrhagic telangiectasia: Vascular implications and risk factors.
Sellier, Jacques; Karam, Carma; Beauchet, Alain; Dallongeville, Axel; Binsse, Stephen; Blivet, Sandra; Bourgault-Villada, Isabelle; Charron, Philippe; Chinet, Thierry; Eyries, Mélanie; Fagnou, Carole; Lesniak, Jérome; Lesur, Gilles; Lucas, Jérome; Nicod-Tran, Agnès; Ozanne, Augustin; Palmyre, Aurélien; Soubrier, Florent; El Hajjam, Mostafa; Lacombe, Pascal.
Afiliação
  • Sellier J; Ambroise Paré Hospital, AP-HP, Boulogne-Billancourt, University of Versailles-Saint Quentin en Yvelines, France.
  • Karam C; Ambroise Paré Hospital, AP-HP, Boulogne-Billancourt, University of Versailles-Saint Quentin en Yvelines, France.
  • Beauchet A; Ambroise Paré Hospital, AP-HP, Boulogne-Billancourt, University of Versailles-Saint Quentin en Yvelines, France.
  • Dallongeville A; Ambroise Paré Hospital, AP-HP, Boulogne-Billancourt, University of Versailles-Saint Quentin en Yvelines, France.
  • Binsse S; Ambroise Paré Hospital, AP-HP, Boulogne-Billancourt, University of Versailles-Saint Quentin en Yvelines, France.
  • Blivet S; Ambroise Paré Hospital, AP-HP, Boulogne-Billancourt, University of Versailles-Saint Quentin en Yvelines, France.
  • Bourgault-Villada I; Ambroise Paré Hospital, AP-HP, Boulogne-Billancourt, University of Versailles-Saint Quentin en Yvelines, France.
  • Charron P; Pitié-Salpêtrière Hospital, Department of Genetics, AP-HP, Paris, France.
  • Chinet T; Ambroise Paré Hospital, AP-HP, Boulogne-Billancourt, University of Versailles-Saint Quentin en Yvelines, France.
  • Eyries M; Pitié-Salpêtrière Hospital, Department of Genetics, AP-HP, Paris, France.
  • Fagnou C; Ambroise Paré Hospital, AP-HP, Boulogne-Billancourt, University of Versailles-Saint Quentin en Yvelines, France.
  • Lesniak J; Ambroise Paré Hospital, AP-HP, Boulogne-Billancourt, University of Versailles-Saint Quentin en Yvelines, France.
  • Lesur G; Ambroise Paré Hospital, AP-HP, Boulogne-Billancourt, University of Versailles-Saint Quentin en Yvelines, France.
  • Lucas J; Ambroise Paré Hospital, AP-HP, Boulogne-Billancourt, University of Versailles-Saint Quentin en Yvelines, France.
  • Nicod-Tran A; Ambroise Paré Hospital, AP-HP, Boulogne-Billancourt, University of Versailles-Saint Quentin en Yvelines, France.
  • Ozanne A; Ambroise Paré Hospital, AP-HP, Boulogne-Billancourt, University of Versailles-Saint Quentin en Yvelines, France.
  • Palmyre A; Pitié-Salpêtrière Hospital, Department of Genetics, AP-HP, Paris, France.
  • Soubrier F; Pitié-Salpêtrière Hospital, Department of Genetics, AP-HP, Paris, France.
  • El Hajjam M; Ambroise Paré Hospital, AP-HP, Boulogne-Billancourt, University of Versailles-Saint Quentin en Yvelines, France.
  • Lacombe P; Ambroise Paré Hospital, AP-HP, Boulogne-Billancourt, University of Versailles-Saint Quentin en Yvelines, France.
PLoS One ; 15(1): e0226681, 2020.
Article em En | MEDLINE | ID: mdl-31971937
ABSTRACT

BACKGROUND:

Splenic artery aneurysm (SAA) is a rare but potentially fatal condition. Rupture results in 25% mortality up to 75% in pregnant women with 95% fetal mortality. Brief reports suggest an increased risk of developing SAA in patients with HHT.

METHODS:

We analyzed enhanced multidetector CT data in 186 HHT patients matched (gender and ± 5 year old) with 186 controls. We screened for SAA and recorded diameter of splenic and hepatic arteries and hepatic, pancreatic and splenic parenchymal involvements. We determined by univariate and multivariate analysis, the relationship with age, sex, genetic status, cardiovascular risk factors (CVRF) and visceral involvement.

RESULTS:

SAA concerned 24.7% of HHT patients and 5.4% of controls, p<0.001. Factors associated with increased risk of SAA in HHT were female gender (p = 0.04, OR = 2.12, IC 95% = 1.03-4.50), age (p = 0.0003, OR = 1.04, 95% CI = 1.02-1.06) and pancreatic parenchymal involvement (p = 0.04, OR = 2.13, 95% CI = 1.01-4.49), but not type of mutation, hepatic or splenic parenchymal involvements, splenic size or splenic artery diameter or CVRF.

CONCLUSIONS:

We found a 4.57 higher rate of SAA in HHT patients without evidence of splenic high output related disease or increased CVRF. These results suggest the presence of a vascular intrinsic involvement. It should lead to screening all HHT patients for SAA. The vasculopathy hypothesis could require a change in management as screening of all systemic arteries and even the aorta and to further research in the field.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artéria Esplênica / Telangiectasia Hemorrágica Hereditária / Doenças Vasculares / Aneurisma Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artéria Esplênica / Telangiectasia Hemorrágica Hereditária / Doenças Vasculares / Aneurisma Idioma: En Ano de publicação: 2020 Tipo de documento: Article